LymeX Authorization Act
Sponsor

Full profile: /officials/S000522
Source: Congress.gov · FEC
Cosponsors (3)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2026-02-11
Previously
- Energy and Commerce CommitteeReferred To · 2026-02-11
Plain-English Summary
This bill would authorize funding and support for research, prevention, and treatment programs related to Lyme disease, a tick-borne illness that affects thousands of Americans each year. The legislation aims to improve how the disease is diagnosed, managed, and studied, potentially benefiting patients dealing with Lyme disease as well as public health agencies working to reduce infections. The bill is currently under review by the House Committee on Energy and Commerce.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR5160Stem Cell Therapeutic and Research Reauthorization Act of 2025Referred to Committee · 2026-07-02
- HR4348To reauthorize the Kay Hagan Tick Act, and for other purposes.Reported by Committee · 2026-07-02
- HRES1400Condemning the People's Republic of China's Law on the Promotion of Ethnic Unity and Progress and the Chinese Communist Party's campaign of forced assimilation against ethnic and religious minorities.Referred to Committee · 2026-06-30
- HR9531Preventing Stomach Cancer in Our Nation’s Heroes ActReferred to Committee · 2026-06-29